RESUMEN
Plasma cell hepatitis (PCH), also known as "de novo autoimmune" hepatitis, is an increasingly recognized, but suboptimally named and poorly understood, category of late allograft dysfunction strongly resembling autoimmune hepatitis (AIH): They share plasma-cell-rich necro-inflammatory activity on biopsy, autoantibodies and steroid responsiveness, but overlap with rejection is problematic. A retrospective study of clinical, serological, histopathological and IgG4 immunohistological features of PCH (n = 20) in liver allograft recipients, native liver AIH (n = 19) and plasma-cell-rich renal allograft rejection (n = 20) showed: (1) high frequency (44%) of HLA-DR15; (2) less female predominance (p = 0.03) and (3) n = 9/20 PCH recipients showed >25 IgG4+ plasma cells/high-power field (IgG4+ PCH) versus AIH (n = 1/19, p = 0.008) or plasma-cell-rich kidney rejection (n = 2/20, p = 0.03). The IgG4+ PCH (n = 9) subgroup showed lower alanine transaminase (ALT) (p < 0.01) and aspartate transaminase (AST) (p < 0.05) at index biopsy but (a) higher plasma cell number/percentage, (b) more aggressive-appearing portal/periportal and perivenular necro-inflammatory activity and (c) more severe portal/periportal fibrosis than IgG4- PCH (n = 11). Significant demographic, histopathologic and plasma cell phenotype differences between PCH and AIH suggest distinct pathogenic mechanisms for at least the IgG4+ PCH subgroup likely representing an overlap between allo- and auto-immunity. IgG4+ PCH was associated with fibrosis, but also highly responsive to increased immunosuppression.
Asunto(s)
Hepatitis C/patología , Hepatitis Autoinmune/patología , Inmunoglobulina G/inmunología , Trasplante de Hígado/efectos adversos , Células Plasmáticas/patología , Complicaciones Posoperatorias , Adulto , Anciano , Anciano de 80 o más Años , Aloinjertos , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/patología , Femenino , Estudios de Seguimiento , Factores de Transcripción Forkhead/metabolismo , Hepacivirus/aislamiento & purificación , Hepatitis C/inmunología , Hepatitis C/virología , Hepatitis Autoinmune/inmunología , Hepatitis Autoinmune/virología , Humanos , Técnicas para Inmunoenzimas , Inmunoglobulina G/metabolismo , Hepatopatías/inmunología , Hepatopatías/cirugía , Hepatopatías/virología , Masculino , Persona de Mediana Edad , Células Plasmáticas/inmunología , Células Plasmáticas/virología , Pronóstico , Estudios Retrospectivos , Adulto JovenRESUMEN
C4d-assisted recognition of antibody-mediated rejection (AMR) in formalin-fixed paraffin-embedded tissues (FFPE) from donor-specific antibody-positive (DSA+) renal allograft recipients prompted study of DSA+ liver allograft recipients as measured by lymphocytotoxic crossmatch (XM) and/or Luminex. XM results did not influence patient or allograft survival, or cellular rejection rates, but XM+ recipients received significantly more prophylactic steroids. Endothelial C4d staining strongly correlates with XM+ (<3 weeks posttransplantation) and DSA+ status and cellular rejection, but not with worse Banff grading or treatment response. Diffuse C4d staining, XM+, DSA+ and ABO- incompatibility status, histopathology and clinical-serologic profile helped establish an isolated AMR diagnosis in 5 of 100 (5%) XM+ and one ABO-incompatible, recipients. C4d staining later after transplantation was associated with rejection and nonrejection-related causes of allograft dysfunction in DSA- and DSA+ recipients, some of whom had good outcomes without additional therapy. Liver allograft FFPE C4d staining: (a) can help classify liver allograft dysfunction; (b) substantiates antibody contribution to rejection; (c) probably represents nonalloantibody insults and/or complete absorption in DSA- recipients and (d) alone, is an imperfect AMR marker needing correlation with routine histopathology, clinical and serologic profiles. Further study in late biopsies and other tissue markers of liver AMR with simultaneous DSA measurements are needed.
Asunto(s)
Complemento C4b/inmunología , Prueba de Histocompatibilidad/métodos , Trasplante de Hígado , Fragmentos de Péptidos/inmunología , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Transplant glomerulitis is an increasingly recognized lesion in renal transplant biopsies. To develop a refined grading system, we defined glomerulitis by the presence of ≥5 leukocytes/glomerulus and evaluated 111 biopsies using three different grading systems: (i) percentage of glomerular involvement, (ii) peak inflammation in the most severely affected glomerulus and (iii) presence/absence of endocapillary occlusion by inflammatory cells. Endocapillary occlusion had no impact on graft survival, but was associated with increased serum creatinine, proteinuria and subsequent transplant glomerulopathy. Grading based on either percent or peak glomerular involvement correlated with graft failure and peritubular capillaritis. However, the percent glomerular involvement method had the additional advantage of displaying associations with: concurrent proteinuria, focal or diffuse immunoperoxidase peritubular capillary C4d staining, 1-year postbiopsy serum creatinine, subsequent detection of donor-specific antibody and development of transplant glomerulopathy. Patients with >75% glomerular involvement also revealed persistent high-grade glomerulitis on follow-up biopsies despite antirejection treatment. In conclusion, grading of glomerulitis is a meaningful exercise, and a quantification system based on percentage of glomerular involvement shows the most robust associations with clinical parameters and prognosis.
Asunto(s)
Glomerulonefritis/clasificación , Glomérulos Renales/patología , Trasplante de Riñón/efectos adversos , Adulto , Anciano , Anciano de 80 o más Años , Biopsia , Creatinina/orina , Femenino , Glomerulonefritis/patología , Rechazo de Injerto/patología , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/patología , Pronóstico , Proteinuria/etiología , Estudios RetrospectivosRESUMEN
BACKGROUND: Brush cytology of biliary strictures to diagnose pancreaticobiliary malignancy suffers from poor sensitivity. AIM: To improve the diagnostic yield of pancreaticobiliary brush cytology through analysis of tumour suppressor gene linked microsatellite marker loss of heterozygosity (LOH) and k-ras codon 12 mutation detection. METHODS: Twenty six patients with biliary strictures underwent endoscopic retrograde cholangiography with brush cytology. A panel of 12 polymorphic microsatellite markers linked to six tumour suppressor genes was developed. Genomic DNA from cell clusters acquired from brush cytology specimens and microdissected surgical malignant and normal tissue underwent polymerase chain amplification reaction (PCR). PCR products were compared for LOH and k-ras codon 12 mutations. RESULTS: Seventeen patients were confirmed to have pancreaticobiliary adenocarcinoma. Nine patients had benign strictures (eight proven surgically, one by follow up). Cytomorphological interpretation was positive for malignancy (n = 8), indeterminate (n = 10), and negative for malignancy (n = 8). Selected malignant appearing cytological cell clusters and microdissected histological samples from cancer showed abundant LOH characteristic of malignancy while brushings from nine cases without cancer carried no LOH (p<0.001). LOH and k-ras mutations profile of the cytological specimens was almost always concordant with the tissue samples. Presence of k-ras mutation predicted malignancy of pancreatic origin (p<0.001). CONCLUSION: LOH and k-ras codon 12 mutation analysis of PCR amplified DNA from biliary brush cytology discriminates reactive from malignant cells, with 100% sensitivity, specificity, and accuracy. Minor variations in LOH in brushings and in different sites within the same tumour likely reflect intratumoral mutational heterogeneity during clonal expansion of pre- and neoplastic lineages.
Asunto(s)
Adenocarcinoma/diagnóstico , Neoplasias de los Conductos Biliares/diagnóstico , Pérdida de Heterocigocidad , Repeticiones de Microsatélite/genética , Neoplasias Pancreáticas/diagnóstico , Adenocarcinoma/genética , Adenocarcinoma/cirugía , Neoplasias de los Conductos Biliares/genética , Neoplasias de los Conductos Biliares/cirugía , Colangiopancreatografia Retrógrada Endoscópica , Citodiagnóstico/métodos , Análisis Mutacional de ADN/métodos , Genes ras , Genotipo , Humanos , Neoplasias Pancreáticas/genética , Neoplasias Pancreáticas/cirugíaRESUMEN
Distinguishing thyroid follicular adenoma from minimally invasive or encapsulated angioinvasive carcinoma can be diagnostically challenging. In some cases, tumors are distorted, fragmented, or stripped of their capsule, and a definitive diagnosis becomes nearly impossible. In other cases, the foci of capsular and/or vascular invasion are subtle, thus making the diagnosis of carcinoma difficult. We developed a microdissection genotyping assay for assessing a panel of tumor-suppressor genes for loss of heterozygosity mutations. The frequency of allelic loss (FAL) in follicular-derived neoplasms correlates with the histologic aggressiveness of the tumor. Furthermore, we calculated the amount of genetic heterogeneity within each tumor, as a second important measure of a tumor's ability for clonal expansion and a surrogate marker for its malignant potential. The follicular adenomas had a low FAL (average 9%) and low intratumoral heterogeneity (5% variability). The minimally invasive and encapsulated angioinvasive carcinomas had an intermediate FAL (average 30%) and intermediate intratumoral heterogeneity (10% variability). The widely invasive carcinomas had a high FAL (average 53%) and high intratumoral heterogeneity (24% variability). Although a larger retrospective study is needed to correlate genotyping studies with patient outcome and prognosis, our results indicate that performing a mutational genotyping assay can stratify tumors into the histologically well-defined categories of adenomas, minimally invasive/angioinvasive carcinomas, and widely invasive follicular carcinomas.
Asunto(s)
Adenoma/genética , Adenoma/patología , Disección/métodos , Neoplasias de la Tiroides/genética , Neoplasias de la Tiroides/patología , Cartilla de ADN/química , ADN de Neoplasias/análisis , Genes Supresores de Tumor , Genotipo , Humanos , Pérdida de Heterocigocidad , Repeticiones de Minisatélite , Invasividad Neoplásica/genética , Invasividad Neoplásica/patología , Reacción en Cadena de la Polimerasa , PronósticoRESUMEN
CONTEXT: A recurring problem in surgical pathology practice is specimen mix-up and floater contamination. While many cases can be resolved histologically, a significant number remain unclear and may have serious clinical and medicolegal implications. OBJECTIVES: To design a microdissection and genotyping assay to identify contaminating floater tissues in paraffin-embedded tissues that is optimized for small samples, and to use the assay to resolve a series of clinical cases with floater tissues. MATERIALS AND METHODS: Twenty-one cases of possible tissue floater contamination in paraffin-embedded tissue blocks were included. Using 4 unstained, 4-microm-thick histologic sections, multiple sites were microdissected under direct visualization either by hand or by laser capture microdissection. Nonneoplastic and neoplastic tissues were sampled. Polymerase chain reaction was performed for a panel of 10 polymorphic microsatellite markers at 1p34, 3p26, 5q21, 9p21, 10q23, and 17p13. Allele size and content were analyzed semiquantitatively by fluorescent capillary electrophoresis, and the genotypes for the tissues in the paraffin-embedded tissue blocks were compared for identity. RESULTS: Tissue identification was successful in all cases, despite small tissue sample size and fixation effects. Comparative analysis of neoplastic tissue floaters and the presumptive source tumor was performed when possible to control for possible allelic loss or microsatellite instability. CONCLUSIONS: Microdissection and genotyping are effective and reliable means to objectively resolve problems of possible floater contamination. Even minute tissue samples provide sufficient DNA template for polymerase chain reaction microsatellite analysis. Because of the potential clinical implications of floaters, we recommend that all suspected floaters that would change a diagnosis from benign to malignant be subjected to genotyping assay to confirm the identity of the floater tissue.
Asunto(s)
Disección/métodos , Adhesión en Parafina/métodos , Fijación del Tejido/métodos , Biopsia/efectos adversos , Biopsia/métodos , ADN de Neoplasias/análisis , Marcadores Genéticos/genética , Genotipo , Humanos , Repeticiones de Microsatélite/genética , Neoplasias/genética , Neoplasias/patología , Adhesión en Parafina/normas , Polimorfismo Genético/genética , Manejo de Especímenes/efectos adversos , Fijación del Tejido/normasAsunto(s)
Dermatoglifia del ADN , Metástasis de la Neoplasia/diagnóstico , Recurrencia Local de Neoplasia/diagnóstico , Neoplasias Primarias Secundarias/diagnóstico , Adenocarcinoma/genética , Adenocarcinoma/patología , Adenocarcinoma/secundario , Neoplasias del Colon/genética , Neoplasias del Colon/patología , Análisis Mutacional de ADN , Disección , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Invasividad Neoplásica , Metástasis de la Neoplasia/genética , Recurrencia Local de Neoplasia/genética , Neoplasias Primarias Secundarias/genética , Biopsia del Ganglio Linfático CentinelaRESUMEN
A case of gastrointestinal stromal tumor (GIST) in stomach was presented. Serial barium meal x-ray examinations revealed an enlarging elevated lesion on the fornix of the stomach. Tumor volume doubling time was found to be 299 days. Microscopic and immunohistochemical studies of the resected tumor disclosed GIST, uncommitted type, low grade malignant/potentially malignant. A radiographic feature of this rare type of gastric submucosal tumor was demonstrated in this report.
Asunto(s)
Neoplasias Gástricas/diagnóstico por imagen , Femenino , Humanos , Persona de Mediana Edad , Radiografía , Neoplasias Gástricas/patologíaRESUMEN
Most extrahepatic bile duct carcinomas (EBDC) are characterized by a striking stromal response (desmoplasia). Our previous studies showed deposition of type IV collagen in the desmoplastic stroma beyond the basement membrane. Although type IV collagen is expressed in EBDC, little is known about the pattern of deposition in tumor stroma and how this matrix component influences the behavior of tumor cells. With the progression of desmoplasia in EBDC, different changes occurred in the quantity and localization of type IV collagen from that of type I collagen. Type I collagen was diffusely distributed in the stroma and appeared to be concentrated in the center of the tumors. In contrast, type IV collagen was deposited in the interstitium alongside carcinoma cells at the tumors' periphery. Weak or no type IV collagen deposition was detected in the more central portion of the tumors containing sclerotic collagens. To investigate the role of stromal type IV collagen in tumor cell proliferation, EBDC cell lines were cultured in a three-dimensional matrix containing varying compositions of type I collagen and type IV collagen. They were also assayed for cell adhesion and migration using in vitro models. Type IV collagen more extensively stimulated tumor cell proliferation, adhesion and migration in a dose-dependent manner than did type I collagen. All of these results suggest that modified tumor stroma with the presence of type IV collagen in EBDC provides a better environment for tumor growth and invasion.
Asunto(s)
Adenocarcinoma/metabolismo , Neoplasias de los Conductos Biliares/metabolismo , Conductos Biliares Extrahepáticos/metabolismo , Colágeno Tipo IV/metabolismo , Adenocarcinoma/patología , Antígenos Nucleares , Neoplasias de los Conductos Biliares/patología , Conductos Biliares Extrahepáticos/patología , Biomarcadores de Tumor/análisis , Western Blotting , División Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Colágeno Tipo I/genética , Colágeno Tipo I/metabolismo , Colágeno Tipo IV/genética , Relación Dosis-Respuesta a Droga , Humanos , Técnicas para Inmunoenzimas , Hibridación in Situ , Proteínas de Neoplasias/análisis , Proteínas Nucleares/metabolismo , ARN Mensajero/metabolismo , ARN Neoplásico/análisis , Células del Estroma/metabolismo , Células del Estroma/patología , Factor de Crecimiento Transformador beta/metabolismo , Factor de Crecimiento Transformador beta1 , Células Tumorales Cultivadas/efectos de los fármacosRESUMEN
A rare case of composite glandular-endocrine cell carcinoma of the common bile duct is presented. Histologically, this tumor consisted of adenocarcinoma and small-cell neuroendocrine carcinoma, with a transition between the two components. The two distinct areas of the tumor were immunohistochemically different, whereas the transitional zone exhibited characteristics of both areas. These features suggest that the tumor arose from a multipotential stem cell. Although it has been reported that the presence of neuroendocrine differentiation in carcinomas indicates a poor prognosis, the patient in the present case was well at the time of writing this report. This may be due to the fact that adenocarcinoma, which characteristically has a low proliferative activity, constituted the majority of the tumor.
Asunto(s)
Adenocarcinoma/patología , Neoplasias de los Conductos Biliares/patología , Carcinoma Neuroendocrino/patología , Neoplasias Primarias Múltiples/patología , Adenocarcinoma/química , Adenocarcinoma/secundario , Adenocarcinoma/cirugía , Anciano , Anciano de 80 o más Años , Neoplasias de los Conductos Biliares/química , Neoplasias de los Conductos Biliares/cirugía , Carcinoma Neuroendocrino/química , Carcinoma Neuroendocrino/secundario , Carcinoma Neuroendocrino/cirugía , División Celular , Colangiografía , Femenino , Humanos , Técnicas para Inmunoenzimas , Antígeno Ki-67/análisis , Ganglios Linfáticos/patología , Invasividad Neoplásica/patología , Neoplasias Primarias Múltiples/química , Neoplasias Primarias Múltiples/cirugíaRESUMEN
Expression of hepatocyte growth factor (HGF) and c-Met (HGF receptor) has been reported in many neoplasms. We investigated coexpression of HGF and c-Met to determine the role of the HGF/c-Met pathway in breast carcinoma, especially at the cancer front. Eighty-eight cases of carcinoma of the breast were studied by immunohistochemistry and by in situ hybridization for HGF and c-Met expression. The staining pattern was termed "front accentuation pattern" when it was most conspicuous at the cancer front. HGF and c-Met proteins were expressed in cancer and stromal cells, with autocrine and paracrine patterns. The front accentuation pattern of c-Met was observed in cancer cells, but not in stromal cells. The front accentuation pattern was not observed in HGF. Coexpression of HGF and c-Met at the cancer front was correlated with histologic grade, reduced patient survival and a high Ki-67 labeling index. Our findings suggest that the HGF/c-Met pathway acts primarily as a mitogen, especially at the cancer front, in a paracrine manner and affects some clinical factors, including patient survival.
Asunto(s)
Neoplasias de la Mama/metabolismo , Carcinoma Ductal de Mama/metabolismo , Factor de Crecimiento de Hepatocito/biosíntesis , Proteínas Proto-Oncogénicas c-met/biosíntesis , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias de la Mama/genética , Neoplasias de la Mama/mortalidad , Neoplasias de la Mama/patología , Carcinoma Ductal de Mama/genética , Carcinoma Ductal de Mama/mortalidad , Carcinoma Ductal de Mama/secundario , ADN de Neoplasias/análisis , Femenino , Factor de Crecimiento de Hepatocito/genética , Humanos , Inmunohistoquímica , Hibridación in Situ , Antígeno Ki-67/análisis , Ganglios Linfáticos/patología , Metástasis Linfática , Persona de Mediana Edad , Estadificación de Neoplasias , Proteínas Proto-Oncogénicas c-met/genética , ARN Mensajero/metabolismo , Tasa de SupervivenciaRESUMEN
Pancreatic ductal adenocarcinoma (PDAC) is a widely known severe malignancy with a poor prognosis. Perineural invasion extending to the extra-pancreatic nerve plexus, a significant concern in the treatment is frequently present in this cancer. We analyzed immunohistochemical expression of neurotrophins (NGF, BDNF, NT-3) and the cognate receptors, Trk tyrosine kinase receptor family (TrkA, B, C) and p75NGFR in 28 surgically resected PDAC specimens. A comparative study between several clinicopathologic factors and Trk receptors revealed a significant correlation between increased expression of TrkA and cancer proliferation, as well as TrkC and cancer invasion, including venous and perineural invasion. The present findings revealed a novel mechanism in PDAC progression that is mediated via a NTs-Trk interaction.
Asunto(s)
Adenocarcinoma/química , Biomarcadores de Tumor/análisis , Conductos Pancreáticos , Neoplasias Pancreáticas/química , Neoplasias del Sistema Nervioso Periférico/química , Polisacáridos/análisis , Receptor trkA/análisis , Receptor trkB/análisis , Receptor trkC/análisis , Adenocarcinoma/patología , Adulto , Anciano , Factor Neurotrófico Derivado del Encéfalo/análisis , División Celular , Femenino , Humanos , Técnicas para Inmunoenzimas , Antígeno Ki-67/análisis , Tumores de Vasos Linfáticos , Masculino , Persona de Mediana Edad , Invasividad Neoplásica , Estadificación de Neoplasias , Neovascularización Patológica , Neurotrofina 3/análisis , Neoplasias Pancreáticas/patología , Neoplasias del Sistema Nervioso Periférico/patología , Receptores de Factor de Crecimiento Nervioso/análisisAsunto(s)
Adenocarcinoma/metabolismo , Adenocarcinoma/patología , Factor Estimulante de Colonias de Granulocitos/metabolismo , Neoplasias Pancreáticas/metabolismo , Neoplasias Pancreáticas/patología , Adenocarcinoma/diagnóstico , Autopsia , Biopsia con Aguja , Progresión de la Enfermedad , Resultado Fatal , Humanos , Fallo Hepático/diagnóstico , Masculino , Persona de Mediana Edad , Neoplasias Pancreáticas/diagnóstico , Índice de Severidad de la EnfermedadRESUMEN
The present study investigated the pathogenesis of desmoplastic stroma formation, which is characteristic of most bile duct carcinomas and other scirrhous carcinomas. Using immunohistochemical analysis, the expression of collagen types I and IV, laminin and TGF-beta1 was examined in human extrahepatic bile duct carcinoma and compared with gastric and colon carcinoma. In addition to delineating the basement membranes of carcinoma nests and blood vessels, collagen type IV was present along the thick bundles of collagenous fibers in the stroma of extrahepatic bile duct carcinoma and scirrhous gastric carcinoma. The immunoreactivity of collagen type IV was strong in the adjacent or surrounding interstitium of tumor cell nests, but was absent or weak in older, more central portions of the tumor that contained sclerotic collagen. In situ hybridization demonstrated active expression of collagen alpha1(IV) mRNA in extrahepatic bile duct carcinoma and scirrhous gastric carcinoma cells. These results suggest that, although collagen type IV is typically a component of the basement membrane, it is expressed in the interstitial stroma of extrahepatic bile duct carcinoma and scirrhous gastric carcinoma where it may play a role in desmoplastic stroma formation.
Asunto(s)
Adenocarcinoma/metabolismo , Neoplasias de los Conductos Biliares/metabolismo , Conductos Biliares Extrahepáticos/metabolismo , Colágeno/metabolismo , Adenocarcinoma/patología , Membrana Basal/metabolismo , Membrana Basal/patología , Neoplasias de los Conductos Biliares/patología , Conductos Biliares Extrahepáticos/patología , Colágeno/genética , Neoplasias del Colon/metabolismo , Neoplasias del Colon/patología , Humanos , Técnicas para Inmunoenzimas , Hibridación in Situ , Laminina/metabolismo , ARN Mensajero/metabolismo , Neoplasias Gástricas/metabolismo , Neoplasias Gástricas/patología , Factor de Crecimiento Transformador beta/metabolismo , Factor de Crecimiento Transformador beta1RESUMEN
We investigated the ability of lipopolysaccharide (LPS) as an adjuvant to induce autoimmune arthritis. LPS from Escherichia coli was intraperitoneally injected into DBA/1J mice together with the joint cartilage component type II collagen (CII) on day 0. Thereafter, the injection of CII and LPS was continued every 2 weeks up to day 56. The results showed that mice injected with CII plus LPS had signs of arthritis on day 55 and the joint inflammation reached a peak on day 75. Injection of CII or LPS alone induced no arthritis. Histologically, marked oedema of synovium and intense infiltration of inflammatory cells, including neutrophils, were observed 3 days after the onset of joint inflammation. Twenty-one days later, there were marked proliferation of synovial tissues with many mononuclear cells and destruction of cartilage. Anti-CII immunoglobulin G (IgG) and IgG2a antibodies were markedly produced in mice injected with CII plus LPS. Pronounced secretion of cytokines, including interleukins-12 and -1beta, interferon-gamma and tumour necrosis factor-alpha, was also observed in these animals. Arthritis was passively transferred into naive syngeneic mice with sera but not with lymphoid cells from mice given CII with LPS. Other types of LPS from Salmonella enteritidis, Salmonella typhimurium and Klebsiella pneumoniae as well as lipid A from E. coli, induced inflammation in joints when administered with CII. Polymixin B sulphate mixed with LPS or lipid A blocked the induction of joint inflammation. These results indicate that LPS appears to play an important role as an adjuvant in the induction of arthritis in which autoimmunity to CII is involved.
Asunto(s)
Adyuvantes Inmunológicos/farmacología , Artritis Experimental/inducido químicamente , Enfermedades Autoinmunes/inducido químicamente , Colágeno/inmunología , Escherichia coli , Lipopolisacáridos/farmacología , Traslado Adoptivo , Animales , Antibacterianos/farmacología , Anticuerpos Antiidiotipos/inmunología , Anticuerpos Monoclonales/sangre , Artritis Experimental/inmunología , Enfermedades Autoinmunes/inmunología , Colágeno/farmacología , Inyecciones Intraperitoneales , Interferón gamma/análisis , Interleucina-1/análisis , Interleucina-12/análisis , Articulaciones/inmunología , Articulaciones/patología , Ganglios Linfáticos/inmunología , Linfotoxina-alfa/análisis , Masculino , Ratones , Ratones Endogámicos DBA , Neutrófilos/inmunología , Polimixina B/farmacología , Bazo/inmunología , Factores de TiempoRESUMEN
We herein describe a 70-year-old male patient who developed colonic necrosis following severe acute pancreatitis. He was referred to our hospital with a diagnosis of acute pancreatitis. In the course of the disease, he developed sudden and massive hematochezia and died. The autopsy findings revealed large bowel ischemia with transmural infarction. The possible pathogenic mechanisms of colonic ischemia are also discussed.
Asunto(s)
Colon/patología , Enfermedades del Colon/etiología , Pancreatitis/complicaciones , Enfermedad Aguda , Anciano , Enfermedades del Colon/patología , Resultado Fatal , Humanos , Masculino , Necrosis , Pancreatitis/diagnóstico por imagen , Pancreatitis/patología , Tomografía Computarizada por Rayos XRESUMEN
Two distinct epithelial lesions (dysplasia and adenoma) and one high-risk condition (anomalous pancreatico-biliary ductal junction; APBDJ) are currently recognized as premalignant stages of gallbladder carcinogenesis. In addition to clinicopathologic observations, recent molecular genetic studies have provided further insight into the pathogenesis and biological behavior of these precursor lesions. In this review, we concentrate on describing the histopathologic and clinicopathologic background and recent molecular genetic findings for each of these putative precursor lesions.
Asunto(s)
Neoplasias de la Vesícula Biliar/patología , Lesiones Precancerosas/patología , Adenoma/patología , Conductos Biliares/anomalías , Conductos Biliares/patología , Neoplasias de la Vesícula Biliar/genética , Genes p53/genética , Genes ras/genética , Humanos , Pérdida de Heterocigocidad , Mutación , Conductos Pancreáticos/anomalías , Conductos Pancreáticos/patologíaRESUMEN
Phlegmonous colitis (PC) is an acute infectious entity caused by bacteria. In this study, we reviewed 8,822 autopsy cases and found 13 cases of PC (0.15%). PC affected 2.43% of patients with hepatic cirrhosis or subacute liver atrophy, both of which were considered to be due to hepatitis viral infection. Before autopsy, none of the cases studied was suspected to involve PC, irrespective of the immediate cause of patient death. Thirteen autopsy cases showed some or all of the following pathohistologic characteristics: (1) involvement of the cecum (9 cases, 76.9%), (2) phlegmonous inflammatory changes and edema in the submucosa (100%), (3) bacterial infection (100%), (4) no microscopically detectable mucosal injuries (12 cases, 92.3%), and (5) acute serositis (peritonitis) (2 cases, 15.4%). These results suggest that PC is an unrecognized, but fatal complication of patients with some hepatic diseases and that PC has pathohistologic characteristics in common with previously reported spontaneous bacterial peritonitis in animal models. PC probably arises due to spontaneous infection in patients with hepatic cirrhosis.
Asunto(s)
Colitis/microbiología , Hepatopatías/complicaciones , Adulto , Anciano , Atrofia , Infecciones Bacterianas/patología , Enfermedad Crónica , Colitis/etiología , Colitis/patología , Escherichia coli/aislamiento & purificación , Femenino , Hepatitis Viral Humana/complicaciones , Histiocitos/patología , Humanos , Mucosa Intestinal/microbiología , Hígado/patología , Cirrosis Hepática/complicaciones , Masculino , Persona de Mediana Edad , Neutrófilos/patologíaRESUMEN
We investigated whether oral administration of LPS exacerbated collagen-induced arthritis (CIA) in mice, which was an experimental model of autoimmune disease. CIA was induced by s.c. injection of type II collagen emulsified with CFA into the base of the tail (day 0) followed by a booster injection on day 21. To examine the ability of LPS to exacerbate CIA, varying doses of LPS were orally administered on day 50. The results showed that administration of LPS was followed by reactivation of CIA in a dose-related fashion. Histologically, on day 55 there were marked edema of synovium proliferated by day 50, new formation of fibrin, and intense infiltration of neutrophils accompanied with a large number of mononuclear cells. Severe destruction of cartilage and subchondral bone was also observed on day 70. The reactivation of CIA by oral administration of LPS was associated with increase in anti-type II collagen IgG and IgG2a Abs as well as varying kinds of cytokines including IL-12, IFN-gamma, IL-1beta, and TNF-alpha. Polymyxin B sulfate given either orally or i.v. suppressed the recurrence of CIA. Increased amounts of LPS were found in sera of mice given the endotoxin orally. LPS from Salmonella enteritidis, Salmonella typhimurium, and Klebsiella pneumoniae and its component, lipid A from Escherichia coli, also reactivated the disease. These findings suggest that LPS from intestinal bacteria may play a role in the exacerbation of autoimmune joint inflammation.
Asunto(s)
Artritis Experimental/inmunología , Artritis Experimental/patología , Colágeno , Lipopolisacáridos/administración & dosificación , Lipopolisacáridos/efectos adversos , Administración Oral , Animales , Artritis Experimental/etiología , Artritis Experimental/prevención & control , Cartílago Articular/patología , Colágeno/inmunología , Citocinas/metabolismo , Inmunoglobulina G/biosíntesis , Inyecciones Intravenosas , Klebsiella pneumoniae/inmunología , Lípido A/administración & dosificación , Lípido A/efectos adversos , Lipopolisacáridos/antagonistas & inhibidores , Lipopolisacáridos/sangre , Masculino , Ratones , Ratones Endogámicos DBA , Polimixina B/administración & dosificación , Salmonella enteritidis/inmunología , Salmonella typhimurium/inmunología , Membrana Sinovial/patología , Factores de TiempoRESUMEN
A male patient synchronously or metachronously underwent six curative resections after diagnoses of cancers in the rectum, urinary bladder, stomach, colon, liver and lung. Five cancers, excluding early colon cancer, were analyzed for instability in seven microsatellite markers and in transforming growth factor beta type II receptor, insulin-like growth factor II receptor and BAX. All analyzed cancers had replication errors and instability in at least one target gene. These results suggest that abnormal DNA mismatch repair system plays a major role in the occurrence of multiple primary cancers in this case.